These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 19956852

  • 1. A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer.
    Van Geer MA, Brevoord D, Kuhlmann KF, Bakker CT, Mizuguchi H, Wesseling JG, Ten Kate FJ, Gouma DJ, Oude Elferink RP, Bosma PJ.
    Int J Oncol; 2010 Jan; 36(1):233-44. PubMed ID: 19956852
    [Abstract] [Full Text] [Related]

  • 2. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG, Bosma PJ, Krasnykh V, Kashentseva EA, Blackwell JL, Reynolds PN, Li H, Parameshwar M, Vickers SM, Jaffee EM, Huibregtse K, Curiel DT, Dmitriev I.
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [Abstract] [Full Text] [Related]

  • 3. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF, van Geer MA, Bakker CT, Dekker JE, Havenga MJ, Elferink RP, Gouma DJ, Bosma PJ, Wesseling JG.
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.
    Toyoda E, Doi R, Kami K, Mori T, Ito D, Koizumi M, Kida A, Nagai K, Ito T, Masui T, Wada M, Tagawa M, Uemoto S.
    Int J Oncol; 2008 Dec; 33(6):1141-7. PubMed ID: 19020746
    [Abstract] [Full Text] [Related]

  • 5. Ephrin A2 receptor targeting does not increase adenoviral pancreatic cancer transduction in vivo.
    van Geer MA, Bakker CT, Koizumi N, Mizuguchi H, Wesseling JG, Oude Elferink RP, Bosma PJ.
    World J Gastroenterol; 2009 Jun 14; 15(22):2754-62. PubMed ID: 19522026
    [Abstract] [Full Text] [Related]

  • 6. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.
    Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH.
    Mol Ther; 2001 Dec 14; 4(6):534-42. PubMed ID: 11735337
    [Abstract] [Full Text] [Related]

  • 7. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D, Duan L, Freimuth P, O'Malley BW.
    Clin Cancer Res; 1999 Dec 14; 5(12):4175-81. PubMed ID: 10632357
    [Abstract] [Full Text] [Related]

  • 8. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA, Rivera AA, Glasgow JN, Le LP, Stoff A, Everts M, Tsuruta Y, Kawakami Y, Bauerschmitz GJ, Mathis JM, Pereboeva L, Seigal GP, Dall P, Curiel DT.
    Gene Ther; 2005 Dec 14; 12(23):1696-706. PubMed ID: 16034451
    [Abstract] [Full Text] [Related]

  • 9. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
    Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, Hayakawa T.
    Gene Ther; 2001 May 14; 8(9):730-5. PubMed ID: 11406768
    [Abstract] [Full Text] [Related]

  • 10. Cancer-targeting gene therapy using tropism-modified adenovirus.
    Tanaka T, Kuroki M, Hamada H, Kato K, Kinugasa T, Shibaguchi H, Zhao J, Kuroki M.
    Anticancer Res; 2007 May 14; 27(6A):3679-84. PubMed ID: 17970028
    [Abstract] [Full Text] [Related]

  • 11. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M, Chen S, Yu T, Escuadro B, Sharma S, Batra RK.
    Clin Cancer Res; 2003 Oct 15; 9(13):4992-9. PubMed ID: 14581374
    [Abstract] [Full Text] [Related]

  • 12. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies.
    Rittner K, Schreiber V, Erbs P, Lusky M.
    Cancer Gene Ther; 2007 May 15; 14(5):509-18. PubMed ID: 17318198
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
    Tseng JF, Farnebo FA, Kisker O, Becker CM, Kuo CJ, Folkman J, Mulligan RC.
    Surgery; 2002 Nov 15; 132(5):857-65. PubMed ID: 12464871
    [Abstract] [Full Text] [Related]

  • 14. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M, Kouri CE, Force S, Chang M, Amin K, Xu K, Blair I, Kaiser L, Albelda S.
    Gene Ther; 1999 Sep 15; 6(9):1600-10. PubMed ID: 10490770
    [Abstract] [Full Text] [Related]

  • 15. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
    Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT, Gerritsen WR.
    Clin Cancer Res; 2001 Mar 15; 7(3):641-50. PubMed ID: 11297260
    [Abstract] [Full Text] [Related]

  • 16. Novel adenoviral gene delivery system targeted against head and neck cancer.
    Li D, Guang W, Abuzeid WM, Roy S, Gao GP, Sauk JJ, O'Malley BW.
    Laryngoscope; 2008 Apr 15; 118(4):650-8. PubMed ID: 18176343
    [Abstract] [Full Text] [Related]

  • 17. Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.
    Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A.
    Mol Ther; 2002 Jun 15; 5(6):695-704. PubMed ID: 12027553
    [Abstract] [Full Text] [Related]

  • 18. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V, Wang W, Sosnowski BA, Hofman FM, Chen TC.
    Neurosurg Focus; 2006 Apr 15; 20(4):E26. PubMed ID: 16709032
    [Abstract] [Full Text] [Related]

  • 19. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
    Noblitt LW, Bangari DS, Shukla S, Mohammed S, Mittal SK.
    Cancer Gene Ther; 2005 Jan 15; 12(1):46-53. PubMed ID: 15486559
    [Abstract] [Full Text] [Related]

  • 20. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines.
    Pearson AS, Koch PE, Atkinson N, Xiong M, Finberg RW, Roth JA, Fang B.
    Clin Cancer Res; 1999 Dec 15; 5(12):4208-13. PubMed ID: 10632362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.